The market for clinical trials has started capturing new geographies owing to the growing awareness of healthcare, bullish demand for therapy methods’ improvements and ongoing technological advancements in the medical equipment industry, enhancing incidence of chronic diseases and the population ageing. Currently, companies engaged in the clinical trials industry tend to move from the mature markets (North America, Oceania and Western Europe) to the emerging ones (Asia, Latin America, Eastern Europe), since the latter ones offer such advantages as a great number of potential patients, lower labor costs and working expenditures and other economic benefits. The US, Canada, Germany and Poland represent the largest country markets for clinical trials. Parexel, Quintles, Chiltern, PPD, Kendle and Omnicare are amid the giants of the worldwide clinical trials market.
Extensive analyses of the clinical trials market are provided in the research reports found under this catalogue. The researches include significant data on the market size, structure and trends, indicate major forces impacting the market. The reports offer detailed evaluation of the market competition and profile key market players. In addition, the future outlooks for the clinical trials market are disposed in the research reports.
Publications found:
339
Sort by:
Clinical Trial Supplies Market by Service [Manufacturing, Packaging (Primary, Secondary), Logistics], Phases, Type (Small Molecules, Biologics, Vaccine), Therapeutic Areas (Oncology, Neurology, Ophthalmology, Dermatology), Region - Global Forecast to 2031
US$ 4,950.00
... clinical trial supplies market Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the clinical trial supplies market Market Development: Comprehensive information about emerging markets. This report analyzes the market for various clinical trial supplies market services and products across geographies Market Diversification ...
October 2026
449 pages
Real-world Evidence Solutions Market by Component [Datasets (Claims, Clinical, Pharmacy, Genomics), Application [Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement], End User (Pharma, Medtech, Payers, Provider), Region- Global Forecast to 2031
US$ 4,950.00
... the top players in the global real world evidence market. The report analyzes the global real world evidence market by component, therapeutic area, end ... upcoming trends and service launches in the global real world evidence market Market Development: Comprehensive information on the lucrative emerging regions ...
September 2026
370 pages
Global Clinical Trial Supplies Market Size Study and Forecast by Type (Products [Investigational Medicinal Products, Comparator Drugs, Ancillary Supplies]; Services [Manufacturing Services, Packaging, Labelling & Blinding Services, Storage & Distribution Services]), By Therapeutic Area (Oncology, Infectious Diseases, Neurology, Cardiology), By Phase, By Modality, By End User, and Regional Forecasts 2026–2036
US$ 3,750.00
The Global Clinical Trial Supplies Market, valued at USD 5.52 Billion in 2025, is projected to reach USD 15.94 Billion by 2036, expanding at a CAGR of 9.3% during the forecast period. The market consi...
August 2026
285 pages
Clinical Trial Technology Market Forecasts To 2034 – Global Analysis By Component (Software, Hardware and Services), Deployment Mode, Clinical Trial Phase, Clinical Trial Design, Technology Type, Delivery Model, Therapeutic Area, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Clinical Trial Technology Market is accounted for $73.4 billion in 2026 and is expected to reach $160.9 billion by 2034 growing at a CAGR of 10.3% during the f...
August 2026
-
Decentralized Clinical Trials (DCT) Market Forecasts To 2034 - Global Analysis By Component (DCT Technology Platforms,Patient Engagement Solutions, Data Management Solutions, Regulatory & Compliance Solutions and Analytics & Digital Trial Solutions), Technology Type, Trial Design Model, Clinical Trial Phase, Therapeutic Area, Study Type, Patient Interaction Approach, Data Collection Method, Service Type, Deployment Mode, Organization Size, Patient Population, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Decentralized Clinical Trials (DCT) Market is accounted for $13.0 billion in 2026 and is expected to reach $43.6 billion by 2034 growing at a CAGR of 16.3% dur...
August 2026
-
Electronic Clinical Outcome Assessment (eCOA) Market Forecasts To 2034 - Global Analysis By Component (Software Solutions and Services), Solution Type, Deployment Mode, Data Collection Mode, Clinical Trial Phase, Clinical Trial Design, Trial Delivery Model, Therapeutic Area, Integration Capability, Enterprise Size, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Electronic Clinical Outcome Assessment (eCOA) Market is accounted for $2.7 billion in 2026 and is expected to reach $10.2 billion by 2034 growing at a CAGR of...
August 2026
-
Immuno-oncology Clinical Trials Market Size, Share and Growth Outlook 2026: By Therapy Type (Checkpoint Inhibitors, CAR-T Cell Therapies, Monoclonal Antibodies, Cancer Vaccines, Cytokines), By Cancer Type, By Phase, By End-User, Companies to 2034.
US$ 3,482.00
The global Immuno-oncology Clinical Trials Market size is forecast to increase from $11.29 Billion in 2026 to $28.76 Billion in 2034 at a CAGR of 12.4% between 2026 and 2034. The Immuno-oncology Clini...
July 2026
190 pages
Oncology Clinical Trials Market Size, Share and Growth Outlook 2026: By Phase Type (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Cancer Type, By Therapy Type, By End-User, Companies to 2034.
US$ 3,482.00
The global Oncology Clinical Trials Market size is forecast to increase from $39.62 Billion in 2026 to $72.47 Billion in 2034 at a CAGR of 7.84% between 2026 and 2034. The Oncology Clinical Trials mar...
July 2026
190 pages
Clinical Trial Management Services Market Size, Share & Trends Analysis Report By Service (Clinical Trial Monitoring, Regulatory Submissions, Clinical Trial Data Management, Medical Writing), By Indication (Oncology, Diabetes, Obesity), By End-use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global clinical trial management services market size was valued at USD 36.2 billion in 2025 and is projected to grow from USD 39.2 billion in 2026 to USD 68.4 billion by 2033, at a CAGR of 8.3% f...
July 2026
120 pages
